Homomultimeric FAP Inhibitor-Based Radioligands for Cancer Theranostics - Design Principles, Structure-Function Relationships, and Preclinical Performance
Favorite
Share
More Options
47

Open in WPS to view all 47 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
